{
    "Trade/Device Name(s)": [
        "EliA GliadinD IgG Immunoassay",
        "EliA GliadinDP IgA Immunoassay",
        "EliA Celiac Positive Control 100",
        "EliA Celiac Positive Control 250",
        "EliA IgG/IgM/IgA Negative Control 100",
        "EliA IgG/IgM/IgA Negative Control 250"
    ],
    "Submitter Information": "Phadia AB",
    "510(k) Number": "K093459",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MST",
        "JJY"
    ],
    "Summary Letter Date": "August 10, 2010",
    "Summary Letter Received Date": "August 11, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "allergy"
    ],
    "Analyte(s)": [
        "IgG antibodies to gliadin",
        "IgA antibodies to gliadin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Phadia 100",
        "Phadia 250"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence immunoassay"
    ],
    "Methodologies": [
        "Non-competitive solid phase ELISA"
    ],
    "Submission Type(s)": [
        "Immunoassay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Phadia EliA GliadinD IgG and GliadinDP IgA immunoassays for the semi-quantitative measurement of anti-gliadin antibodies to aid in celiac disease diagnosis",
    "Indications for Use Summary": "Intended for in vitro semi-quantitative measurement of IgG or IgA antibodies directed to gliadin in human serum and plasma to aid in the diagnosis of celiac disease, used with Phadia 100 and 250 instruments",
    "fda_folder": "Immunology"
}